Alexandria Real Estate Equities, Inc. (NYSE:ARE) is a prominent player in the real estate investment trust (REIT) sector, focusing on the ownership, operation, and development of life science and technology campuses. The company is known for its strategic locations in key urban innovation clusters. Competitors in the REIT space include Boston Properties and Healthpeak Properties.
On November 28, 2025, Evercore ISI set a price target of $72 for ARE, suggesting a potential price increase of about 33.74% from its current price of $53.84. This optimistic outlook comes despite the ongoing class action lawsuit initiated by the Rosen Law Firm, which alleges securities fraud by the company. The lawsuit targets investors who purchased ARE securities between January 27, 2025, and October 27, 2025.
The stock price of ARE is currently $53.84, showing a slight increase of 0.49% or $0.27. During the trading day, the stock fluctuated between $53.40 and $54.45. Over the past year, ARE's stock has seen a high of $111.51 and a low of $48.66, indicating significant volatility. The company's market capitalization is approximately $9.3 billion, with a trading volume of 490,628 shares on the NYSE.
The class action lawsuit could impact investor sentiment and stock performance. However, Evercore ISI's price target suggests confidence in ARE's potential for growth. Investors should consider both the legal proceedings and the stock's historical performance when evaluating their investment in ARE.
